Investing.com - AIM ImmunoTech (NYSE: AIM) reported first quarter EPS of $-0.260, $0.14 worse than the analyst estimate of $-0.120. Revenue for the quarter came in at $62K versus the consensus estimate of $24.33K.
AIM ImmunoTech's stock price closed at $0.45. It is up 2.270% in the last 3 months and up 1.030% in the last 12 months.
AIM ImmunoTech saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See AIM ImmunoTech's stock price’s past reactions to earnings here.
According to InvestingPro, AIM ImmunoTech's Financial Health score is "fair performance".
Check out AIM ImmunoTech's recent earnings performance, and AIM ImmunoTech's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar